HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

por Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Publicado 2012